| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2025 | Feb 19, 2025 | Seres Therapeutics, Inc. | Officer | Sell | 33.8 | -4,416 | -9.97% | ✓ | $3.6K |
| Nov 15, 2024 | Nov 19, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 46.3 | -977 | -2.93% | ✓ | $528.3 |
| Oct 27, 2024 | Oct 29, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 30.0 | -4,334 | -12.47% | ✓ | $3K |
| Aug 15, 2024 | Aug 19, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 42.5 | -973 | -4.43% | ✓ | $817.3 |
| May 15, 2024 | May 17, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 42.5 | -939 | -4.71% | ✓ | $882.7 |
| Feb 15, 2024 | Feb 16, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 20.0 | -4,400 | -20.57% | ✓ | $4.8K |
| Oct 27, 2023 | Oct 31, 2023 | Seres Therapeutics, Inc. | Officer | Sell | 15.0 | -4,232 | -30.79% | ✓ | $5.7K |